1 / 9

Priority of SARC studies for selected sub-types

Priority of SARC studies for selected sub-types. SARC 003 Gem/docetaxel Osteo/Ewings < 2 prior regimens Chondrosarcoma 0-X prior regimens SARC 006 AI/IE 1 st line. SARC 007 Perifosine < 3 prior regimens SARC009 Dasatinib 0-X prior regimens SARC 011 R1507 0-X prior regimens.

irving
Télécharger la présentation

Priority of SARC studies for selected sub-types

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Priority of SARC studies for selected sub-types

  2. SARC 003 Gem/docetaxel Osteo/Ewings < 2 prior regimens Chondrosarcoma 0-X prior regimens SARC 006 AI/IE 1st line SARC 007 Perifosine <3 prior regimens SARC009 Dasatinib 0-X prior regimens SARC 011 R1507 0-X prior regimens Eligibility

  3. Chondrosarcoma • SARC 003: gemcitabine and docetaxel in bone sarcomas • SARC 007: perifosine in chemotherapy insensitive sarcomas (requires documented disease progression for participation) • SARC 009: dasatinib in advanced sarcomas (does not require documented disease progression for participation)

  4. Ewings • SARC 003: gemcitabine and docetaxel in bone sarcomas • SARC 011: IGF-1R for refractory/recurrent subtypes of sarcoma • SARC 009: dasatinib in advanced sarcomas

  5. Alveolar soft part sarcoma • SARC 007: perifosine in chemotherapy insensitive sarcomas • SARC 009: dasatinib in advanced sarcomas • SARC 011: IGF-1R for refractory/recurrent subtypes of sarcoma

  6. MPNST • SARC 006: chemotherapy in high-grade MPNST • SARC 009: dasatinib in advanced sarcomas

  7. Rhabdomyosarcoma • SARC 011: IGF-1R for refractory/recurrent subtypes of sarcoma • SARC 009: dasatinib in advanced sarcomas

  8. LiposarcomaExtraskeletal Myxoid Chondro • SARC 009: dasatinib in advanced sarcomas • SARC 011: IGF-1R for refractory/recurrent subtypes of sarcoma

  9. SARC Principles • Data trumps “BS” • Rhabdomyosarcoma • Ewings OTHERWISE • It’s not over till it’s over • 009 precedes 011 • 003 precedes 007 • In God we trust, everyone else pays cash OR • You vote with your feet

More Related